Dr. Kohlgruber is identifying neoantigens from breast cancer that can be recognized by CD8+ T cells of the immune system.
High-Throughput Identification of CD8+ T-Cell Antigens in Cancer
Life Sciences Research Foundation - Mark Foundation Postdoctoral Fellow (2019-2022)
Ayano Kohlgruber, PhD, Harvard Medical School
Ayano Kohlgruber, PhD